Health
Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer – News-Medical.Net
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis…
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC). In a new study in TheJournal of Molecular Diagnosis, published by Elsevier, investigators provide for the first time a complete overview of biomarker testing, spanning multiple treatment lines, in a single cohort of patients.
Using exploratory data analysis and process-mining techniques in a real-world…
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News19 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General24 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News22 hours agoStar Entertainment faces $36.5m blow if Queen’s Wharf deal flops